Literature DB >> 23035192

Swab protocol for rapid laboratory diagnosis of cutaneous anthrax.

Leslie A Dauphin1, Chung K Marston, Vinod Bhullar, Daniel Baker, Mahmudur Rahman, M Jahangir Hossain, Apurba Chakraborty, Salah Uddin Khan, Alex R Hoffmaster.   

Abstract

The clinical laboratory diagnosis of cutaneous anthrax is generally established by conventional microbiological methods, such as culture and directly straining smears of clinical specimens. However, these methods rely on recovery of viable Bacillus anthracis cells from swabs of cutaneous lesions and often yield negative results. This study developed a rapid protocol for detection of B. anthracis on clinical swabs. Three types of swabs, flocked-nylon, rayon, and polyester, were evaluated by 3 extraction methods, the swab extraction tube system (SETS), sonication, and vortex. Swabs were spiked with virulent B. anthracis cells, and the methods were compared for their efficiency over time by culture and real-time PCR. Viability testing indicated that the SETS yielded greater recovery of B. anthracis from 1-day-old swabs; however, reduced viability was consistent for the 3 extraction methods after 7 days and nonviability was consistent by 28 days. Real-time PCR analysis showed that the PCR amplification was not impacted by time for any swab extraction method and that the SETS method provided the lowest limit of detection. When evaluated using lesion swabs from cutaneous anthrax outbreaks, the SETS yielded culture-negative, PCR-positive results. This study demonstrated that swab extraction methods differ in their efficiency of recovery of viable B. anthracis cells. Furthermore, the results indicated that culture is not reliable for isolation of B. anthracis from swabs at ≥ 7 days. Thus, we recommend the use of the SETS method with subsequent testing by culture and real-time PCR for diagnosis of cutaneous anthrax from clinical swabs of cutaneous lesions.

Entities:  

Mesh:

Year:  2012        PMID: 23035192      PMCID: PMC3502990          DOI: 10.1128/JCM.02076-12

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  40 in total

1.  Virulence and immunogenicity in experimental animals of Bacillus anthracis strains harbouring or lacking 110 MDa and 60 MDa plasmids.

Authors:  I Uchida; K Hashimoto; N Terakado
Journal:  J Gen Microbiol       Date:  1986-02

2.  Association of the encapsulation of Bacillus anthracis with a 60 megadalton plasmid.

Authors:  I Uchida; T Sekizaki; K Hashimoto; N Terakado
Journal:  J Gen Microbiol       Date:  1985-02

3.  Molecular characterization and protein analysis of the cap region, which is essential for encapsulation in Bacillus anthracis.

Authors:  S Makino; I Uchida; N Terakado; C Sasakawa; M Yoshikawa
Journal:  J Bacteriol       Date:  1989-02       Impact factor: 3.490

4.  Anthrax outbreaks in Bangladesh, 2009-2010.

Authors:  Apurba Chakraborty; Salah Uddin Khan; Mohammed Abul Hasnat; Shahana Parveen; M Saiful Islam; Andrea Mikolon; Ranjit Kumar Chakraborty; Be-Nazir Ahmed; Khorsed Ara; Najmul Haider; Sherif R Zaki; Alex R Hoffmaster; Mahmudur Rahman; Stephen P Luby; M Jahangir Hossain
Journal:  Am J Trop Med Hyg       Date:  2012-04       Impact factor: 2.345

Review 5.  Anthrax molecular epidemiology and forensics: using the appropriate marker for different evolutionary scales.

Authors:  Paul Keim; Matthew N Van Ert; Talima Pearson; Amy J Vogler; Lynn Y Huynh; David M Wagner
Journal:  Infect Genet Evol       Date:  2004-09       Impact factor: 3.342

6.  Sequence and analysis of the DNA encoding protective antigen of Bacillus anthracis.

Authors:  S L Welkos; J R Lowe; F Eden-McCutchan; M Vodkin; S H Leppla; J J Schmidt
Journal:  Gene       Date:  1988-09-30       Impact factor: 3.688

7.  Nucleotide sequence of the Bacillus anthracis edema factor gene (cya): a calmodulin-dependent adenylate cyclase.

Authors:  D L Robertson; M T Tippetts; S H Leppla
Journal:  Gene       Date:  1988-12-20       Impact factor: 3.688

8.  Evidence for plasmid-mediated toxin production in Bacillus anthracis.

Authors:  P Mikesell; B E Ivins; J D Ristroph; T M Dreier
Journal:  Infect Immun       Date:  1983-01       Impact factor: 3.441

9.  Swab materials and Bacillus anthracis spore recovery from nonporous surfaces.

Authors:  Laura Rose; Bette Jensen; Alicia Peterson; Shailen N Banerjee; Matthew J Srduino
Journal:  Emerg Infect Dis       Date:  2004-06       Impact factor: 6.883

10.  Evaluation and validation of a real-time polymerase chain reaction assay for rapid identification of Bacillus anthracis.

Authors:  Alex R Hoffmaster; Richard F Meyer; Michael D Bowen; Chung K Marston; Robbin S Weyant; Kathy Thurman; Sharon L Messenger; Erin E Minor; Jonas M Winchell; Max V Rassmussen; Bruce R Newton; J Todd Parker; William E Morrill; Nancy McKinney; Gwen A Barnett; James J Sejvar; John A Jernigan; Bradley A Perkins; Tanja Popovic
Journal:  Emerg Infect Dis       Date:  2002-10       Impact factor: 6.883

View more
  3 in total

1.  Detection of Bacillus anthracis in animal tissues using InBios active anthrax detect rapid test lateral flow immunoassay.

Authors:  C B Kolton; C K Marston; R A Stoddard; C Cossaboom; J S Salzer; T R Kozel; M A Gates-Hollingsworth; C A Cleveland; A T Thompson; M F Dalton; M J Yabsley; A R Hoffmaster
Journal:  Lett Appl Microbiol       Date:  2019-03-28       Impact factor: 2.858

2.  First PCR Confirmed anthrax outbreaks in Ethiopia-Amhara region, 2018-2019.

Authors:  Baye Ashenefe Wassie; Surafel Fantaw; Yonas Mekonene; Amete Mihret Teshale; Yohannis Yitagesu; Estifanos Tsige; Desalegn Getahun; Geremew Tasew; Getachew Abichu; Beyene Moges; Ebba Abate; Takele Abayneh; Taye Zeru; Zewdu Belay; Siobhan M Mor
Journal:  PLoS Negl Trop Dis       Date:  2022-02-10

3.  Investigation and source-tracing of an anthrax outbreak in Gansu Province, China.

Authors:  Deshan Yu; Jian He; Enmin Zhang; Peng Wang; Dongpeng Liu; Yadong Hou; Huimin Zhang; Kongfu Wei; Faxiang Gou; Huijuan Zhang; Wei Li; Jianchun Wei
Journal:  PLoS One       Date:  2018-08-30       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.